News

Quanterix announced “Simoa Accelerator” – a dedicated laboratory environment for clinical sample testing and development allowing broader access to an advanced diagnostic technology that has been fueling research in oncology, neurology, cardiology, infectious disease, etc.

Quanterix announced the opening of The Simoa Accelerator.

CRF Health announced an agreement with EuroQol to launch the EQ-5D web system on its TrialMax Web software platform.

Agreement expands innovative data collection offerings for biopharmaceutical clients

WIRB-Copernicus Group announced that it has been chosen by Cancer Treatment Centers of America to expand its clinical research program.

Strategy will enable CTCA to expand its clinical research capabilities while maintaining the highest standard of human subject protection

It’s clear that the value clinical trials bring to the health and well being of our existence is being recognized and expectations from the public are high.

The development and approval of new vaccines and antivirals to contain and treat the Ebola virus outbreak has become a top priority for the federal government and Congress.

An effective risk mitigation model requires the development of a structured approach to risk identification, analysis and control, from trial inception to completion.

EFPIA is pleased to announce today the official appointment of Joe Jimenez, CEO of Novartis, as its new President.

EFPIA has announced the official appointment of Joe Jimenez, CEO of Novartis, as its new President.

The European Forum for GCP (EFGCP) Geriatric Medicines Working Party is organizing a multi-stakeholder workshop, “Excluded Older People from Clinical Research”

SCRS announced a two-year collaboration with Clinical Ink.

Acquisition Enriches Medidata’s Comprehensive Risk-Based Monitoring Solution, Enabling Safer, Faster and More Insightful Clinical Trial Reviews

SCRS announced a two-year collaboration with Clinical Ink

Medidata announced the availability is enriched solution for risk-based monitoring.

PCORI is launching a $50 million program to fund research on the comparative effectiveness of various approaches for diagnosing and treating hepatitis C.

TrialScope announced the latest release of its PharmaCM platform (v.2.2)

TrialScope announced general availability of the latest release of the PharmaCM platform

Comprehend CEO Rick Morrison shares his thoughts on 2015 predictions for clinical R&D.

The conclusions on vaccination that European Union health ministers adopted on December 1 contain several sound thoughts.

Clinical trials need to become a part of the treatment continuum, not separated from it as it is now.

Company to fund new SCRS Scholarship Program to improve site sustainability through education; becomes first CRO to leverage Site Advocacy Group to improve clinical development process

Biorasi LLC announced that it has completed the acquisition of Advanced Biosciences Research

Leading Global CRO Expands into Western Europe, Establishes its European Headquarters in Frankfurt, Germany

BBK Worldwide and ACRES are collaborating to ensure that patients are a central part of the organization's efforts in standards development